Log in to save to my catalogue

Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap

Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2509109592

Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap

About this item

Full title

Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Neurology, 2021-04, Vol.17 (4), p.231-242

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Onset of many forms of epilepsy occurs after an initial epileptogenic insult or as a result of an identified genetic defect. Given that the precipitating insult is known, these epilepsies are, in principle, amenable to secondary prevention. However, development of preventive treatments is difficult because only a subset of individuals will develop...

Alternative Titles

Full title

Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2509109592

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2509109592

Other Identifiers

ISSN

1759-4758

E-ISSN

1759-4766

DOI

10.1038/s41582-021-00461-4

How to access this item